Medical Science Liaison, Southeast

This role is considered Virtual.

Summary Of Key Responsibilities

• Identify key opinion leaders and cultivate a network of experts for key Alnylam disease areas including Primary Hyperoxaluria Type 1 and Acute Hepatic Porphyrias.
• Develop, maintain, and execute US KOL and US Institution plans within respective geography.
• Conduct and implement a comprehensive disease awareness tactical plan within the respective geography.
• Collaborate with health care professionals to identify opportunities for the development of algorithms and guidelines to facilitate early diagnosis
• Provide in-depth drug mechanism of action and clinical information to health care providers in the respective geography.
• Serve as a liaison to health care professionals and professional organizations and disease state advocacy groups. Support the efforts of patient support groups and educational foundations.
• Provide medical and scientific input into the planning and execution of advisory boards and work with experts to review speaker presentations and provide additional medical background where requested.
• Contribute to Alnylam's achievement of Company objectives for rare disease products.
• Provide educational meeting support at scientific congresses.
• Coordinate required medical, legal, and regulatory review and approval of all field documents for distribution or presentation.
• Require 60-70% travel. Must live within the Southeast US geography.
• Locations: Southeast US (MS AR, TN, KY, AL, GA, FL, SC, NC, VA, WV)
  
  

Qualifications

• PhD, PharmD, DNP or MD with at least 5 years’ industry experience.
• Prior experience engaging Health Care Professionals in a scientifically meaningful exchange.
• Prior experience in rare disease strongly preferred.
• Experience in clinical research, patient recruitment, and investigator-sponsored trials.
• Experience in medical education and KOL management.
• Effective communication of evidence based scientific information.
• Comfort with technology to enable identification of thought leaders.
• Ability to work collaboratively and cross-functionally.
• Capable of managing shifting priorities in a rapidly changing and environment
• Decision-making and accountability.
• Clear alignment with Alnylam Core Values
  
  

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.